Log in

NASDAQ:RARXRa Pharmaceuticals Insider Trades

$47.99
0.00 (0.00 %)
(As of 04/5/2020 04:00 PM ET)
Add
Compare
Today's Range
$47.99
Now: $47.99
$47.99
50-Day Range
$40.51
MA: $46.39
$48.01
52-Week Range
$19.64
Now: $47.99
$48.02
Volume30,200 shs
Average Volume1.85 million shs
Market Capitalization$2.27 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.05

Insider Trades

Ra Pharmaceuticals (NASDAQ:RARX) Insider Buying and Selling Activity

Insider Ownership Percentage: 4.30%

Insider Buying and Selling by Quarter

Ra Pharmaceuticals (NASDAQ RARX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/17/2020Alonso RicardoinsiderSell2,288$44.25$101,244.008,521  
2/18/2020Ramin Farzaneh-FarInsiderSell10,595$46.61$493,832.958,521  
1/17/2020Alonso RicardoInsiderSell2,285$47.02$107,440.702,288  
1/15/2020Ramin Farzaneh-FarInsiderSell10,595$46.95$497,435.258,521  
12/17/2019Alonso RicardoInsiderSell2,285$47.08$107,577.804,573  
11/15/2019Ramin Farzaneh-FarInsiderSell10,595$46.66$494,362.708,521  
10/17/2019Alonso RicardoInsiderSell2,285$46.70$106,709.506,858  
10/15/2019Ramin Farzaneh-FarInsiderSell10,595$46.89$496,799.558,521  
9/16/2019Ramin Farzaneh-FarInsiderSell10,595$25.26$267,629.708,521  
9/12/2019Simon ReadInsiderSell10,000$25.41$254,100.0016,234  
8/23/2019Simon ReadInsiderSell10,000$27.77$277,700.009,143  
7/17/2019Simon ReadInsiderSell10,000$32.95$329,500.0016,234  
7/15/2019Ramin Farzaneh-FarInsiderSell10,595$33.10$350,694.508,521  
6/21/2019Alonso RicardoInsiderSell2,857$23.72$67,768.0411,428  
6/18/2019Simon ReadInsiderSell10,000$22.25$222,500.008,521  
12/14/2018Enterprise Associates 13 L NewMajor ShareholderBuy645,161$15.50$9,999,995.50  
12/14/2018Rajeev M ShahDirectorBuy1,006,452$15.50$15,600,006.00  
12/12/2018Ra Capital Healthcare Fund LpDirectorBuy1,006,452$15.50$15,600,006.00  
2/16/2018Enterprise Associates 13 L NewMajor ShareholderBuy2,000,000$6.00$12,000,000.00  
2/14/2018Ra Capital Healthcare Fund LpMajor ShareholderBuy2,500,000$6.00$15,000,000.00  
6/19/2017Bioventures Ltd NovartisMajor ShareholderSell56,420$21.29$1,201,181.80  
6/7/2017Bioventures Ltd NovartisMajor ShareholderSell12,114$22.63$274,139.82  
6/5/2017Bioventures Ltd NovartisMajor ShareholderSell19,647$23.38$459,346.86  
6/1/2017Bioventures Ltd NovartisMajor ShareholderSell46,261$23.93$1,107,025.73  
5/26/2017Bioventures Ltd NovartisMajor ShareholderSell5,353$25.14$134,574.42  
5/24/2017Bioventures Ltd NovartisMajor ShareholderSell17,451$25.01$436,449.51  
5/18/2017Bioventures Ltd NovartisMajor ShareholderSell9,019$25.50$229,984.50  
5/17/2017Bioventures Ltd NovartisMajor ShareholderSell42,615$25.90$1,103,728.50  
10/31/2016Harry R WellerMajor ShareholderBuy338,462$13.00$4,400,006.00  
10/31/2016Rajeev M ShahDirectorBuy161,538$13.00$2,099,994.00  
(Data available from 1/1/2013 forward)
This page was last updated on 4/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel